Table III.
95% CI
|
|||
---|---|---|---|
Characteristic | Risk estimate | Lower | Upper |
Male gender | 1.773 | 0.561 | 5.602 |
Age ≥40 years | 1.077 | 0.331 | 3.506 |
Disease duration ≥4 years | 0.875 | 0.284 | 2.699 |
Seo’s CIDAI ≥220 points | 2.800 | 0.848 | 9.245 |
Prior AZA treatment | 1.385 | 0.416 | 4.612 |
Undermining ulcer present | 0.477 | 0.156 | 1.464 |
Pancolitis | 2.500 | 0.701 | 8.915 |
C7-HRP positivity | 3.600 | 1.097 | 11.809 |
PSL ≥10,000 mg | 3.429 | 1.010 | 11.643 |
CNI non-responder | 33.750 | 7.447 | 152.951 |
Values in bold print are statistically significant. AZA, azathioprine; CIDAI, complex integrated disease activity index; CI, confidence interval: CNI, calcineurin inhibitor; PSL, prednisolone.